Friday, December 16, 2005

Pfizer Wins

Investors in Pfizer (PFE) have been eagerly waiting for the court ruling on the Lipitor patents. Late today, the court ruled that the Lipitor patents were valid until 2010 and 2011. This is a huge huge win for Pfizer since Lipitor makes up a huge chunk of Pfizer’s sales. Pfizer generated close to $11 billion in Lipitor sales last year. This uncertainty was holding down the stock price, but now there's the all clears signal. The stock jumped 12% in after hours trading on this news and will go much higher. Now I'm glad I didn't sell Pfizer.


At December 27, 2005, Blogger Sean said...

I was happy to get in before the news. Unfortunately, the stock price is trying to fill the gap now.


Post a Comment

<< Home